GlassScriptPhysician profile
Perkin K Stang
NPI 1679616924
$3,425.15
in general payments reported to CMS, 2019-2025
12 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $137 · 2021: $134 · 2022: $1,547 · 2023: $471 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $848.51 | 2022 | |
| Hologic Sales and Service, LLC | $846.66 | 2022-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System, Fluent Fluid Management System |
| Abbvie INC. | $519.31 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Baxter Healthcare | $352.32 | 2021-2023 | Tisseel |
| Amgen INC. | $267.92 | 2019-2021 | |
| Abiomed | $150.00 | 2023 | Impella |
| Olympus America INC. | $115.39 | 2023 | Endoeye Flex 3d Deflectable Videoscope |
| Intuitive Surgical, INC. | $97.67 | 2022 | |
| Lupin INC. | $81.67 | 2019 | |
| Avion Pharmaceuticals | $64.68 | 2020-2023 | Balcoltra |
| Coopersurgical, INC. | $57.18 | 2019 | |
| Exeltis, USA INC. | $23.84 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perkin Stang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.